Join Now

Utah Life Sciences Companies' COVID-19 News

July 22, 2021
Senator Mike Lee Tours Stryker Neurovascular Division

U.S. Senator Mike Lee (R-UT) on July 16 toured Stryker’s Neurovascular Division with division President, Mark Paul, joined by BioUtah President and CEO, Kelvyn Cullimore and members of the Senator’s staff. During the tour, Lee learned about the innovative, best-in-class technologies manufactured at the Salt Lake City facility to treat stroke patients. Stroke is the […]

July 22, 2021
Co-Diagnostics Strengthens IP Portfolio with New International CoPrimer™ Patent

Co-Diagnostics has added to its suite of intellectual property protection after being awarded a patent from the Republic of Korea’s Intellectual Property Office for the Company’s CoPrimer™ technology. Developed in 2013, Co-Diagnostics’ solely-owned CoPrimer technology received its first patent from the US Patent Office in 2018, and underpins the company’s molecular diagnostic test products that […]

July 22, 2021
Biosafety Startup, R-Zero Acquires Leading Workplace Intelligence Platform, CoWorkr

South Salt Lake-based R-Zero, the first biosafety technology company dedicated to creating safer, healthier indoor spaces, announced July 20 its acquisition of CoWorkr, the leading property technology company offering privacy-first space utilization sensors for data-driven workplaces. Fresh off its Series B raise closed in June, R-Zero’s first acquisition accelerates speed to market for an IoT […]

July 22, 2021
Owlet to Begin Trading on the New York Stock Exchange

Owlet on July 15 announced that it completed its business combination with Sandbridge Acquisition Corporation, a special purpose acquisition company (SPAC) as previously announced in February. Following the transaction, the company was renamed Owlet, Inc, and its Class A common stock and warrants began trading on the New York Stock Exchange under the symbols “OWLT” […]

July 22, 2021
Sera Prognostics Announces Pricing of Initial Public Offering

Sera Prognostics – The Pregnancy Company® – located in Salt Lake City, Utah, has announced the pricing of its initial public offering of 4,687,500 shares of its common stock at a price to the public of $16.00 per share. Sera is a women’s health diagnostics company dedicated to improving the lives of women and babies […]

July 15, 2021
Utah Based MMV Launches Second Healthcare Fund

MMV, a Salt Lake City-based seed-stage venture capital firm, announced the first close of its second fund, MMVII. The fund will be managed by Managing Partners Branden Rosenhan, MD, Saumitra Thakur, MD and General Partner and COO Katelin Roberts. “95% of our first fund investors have joined us in MMVII, many stepping up their commitments. […]

July 8, 2021
Turner Imaging Expands Internationally

Turner Imaging Systems has entered a distribution agreement with MIS Healthcare to market its Smart-C fluoroscopic Mini C-Arm in the UK and Ireland. MIS Healthcare, with headquarters in London, is a large, independent medical imaging equipment supplier throughout the UK and Ireland, servicing NHS and HSE hospitals as well as private hospitals, clinics, screening centers […]

July 8, 2021

Major League Baseball has expanded its partnership with Spectrum Solutions to facilitate a COVID-19 testing program throughout the 2021 Minor League season. Under the partnership, Spectrum will be supplying all Major League and Minor League teams with its innovative SDNA-1000 saliva collection kits for all player and staff testing. Spectrum Solutions has also consulted with […]

July 8, 2021
Spectrum Solutions Wins Best of State Award for Medical Innovation

In May, Spectrum Solutions was awarded the prestigious Best of State® award in the Science & Technology category for Medical Innovation. Spectrum received this honor for its SDNA-1000 Saliva Collection Device. “At Spectrum Solutions, our focus is on creating forward-looking and scalable end-to-end solutions for applications such as clinical diagnostics and commercialized product plans.” said […]

July 8, 2021
BlueWind Medical Reaches 100th Patient for the OASIS Study of the RENOVA™ iStim System

Park City based and BioUtah member, BlueWind Medical, has announced its 100th patient implant in their pivotal study – Overactive Bladder (OAB) Stimulation System Study (OASIS) – for treating overactive bladder symptoms using the company’s innovative medical device the RENOVA™ iStim. The milestone marks an important step towards FDA clearance for the device. “The 100th […]

July 2, 2021
Thermo Fisher Opening New Manufacturing Facility In Ogden

Thermo Fisher is opening a new facility at the Boyer Business Depot Ogden, hiring 450 employees by 2022. Ogden City announced the plans on Tuesday. “Thermo Fisher has had a presence in Utah for many years,” said Kelvyn Cullimore, president and CEO of BioUtah. “The company’s expansion in Ogden reflects their commitment to Utah jobs, […]

July 1, 2021

Recursion has announced a multi-year collaboration with Mila, the Quebec Artificial Intelligence Institute, to accelerate Recursion’s machine learning capabilities. Recursion will open office space within Mila and build a team focused on using machine learning for tech-enabled drug discovery. “Recursion is executing at the forefront of multiple technical fields including biology, chemistry, automation, engineering and […]

July 1, 2021
Epitel Publishes First Peer-Reviewed Research Paper

BioUtah congratulates the Epitel team on its first peer-reviewed manuscript, “Electrographic Seizure Monitoring with a Novel, Wireless, Single-Channel EEG Sensor,” comparing Epilog EEG to the clinical gold-standard of traditional EEG. The publication appears in Clinical Neurophysiology Practice. People living with epilepsy could benefit by having a more accurate and objective wearable EEG system for counting seizures […]

July 1, 2021
RenalytixAI’s KidneyIntelX™ Demonstrates Effectiveness In Monitoring Therapeutic Response in kidney health for Adults with type 2 diabetes

Renalytix has announced new data demonstrating KidneyIntelX™ can be effective at monitoring therapeutic response and improvements in kidney health in adults with type 2 diabetes. The data from an international study of 1,100 individuals with diabetic kidney disease (DKD) in the CANagliflozin Cardiovascular Assessment Study (CANVAS), was presented at the American Diabetes Association 81st Scientific Sessions […]

June 25, 2021
Co-Diagnostics, Inc Receives CE Marking for Direct Saliva SARS-CoV-2 Test

Co-Diagnostics has obtained regulatory authorization to be sold as an in vitro diagnostic (“IVD”) for the diagnosis of COVID-19 in markets that accept CE markings. The Co-Diagnostics Logix Smart DS test kit detects the presence of certain genes of the COVID-19 virus directly from human saliva samples while eliminating RNA extraction of the samples. Eliminating […]